Pharmacology Session Presentations
| Speaker | Presentation Title |
|---|---|
| Natalie Germann | In situ theological testing of soft gel materials for pharmaceutical applications |
| Allan Mathews | Therapeutic Drug Monitoring of Anti-Epileptic Drugs in a Tertiary Hospital in Malaysia. |
| Stephen Shrewsbury | The Upper Nasal Space: An efficient route for systemic drug delivery |
| Juan Sanchez-Ramos | Nanoparticles Designed for Nose-to-brain Delivery of Gene Therapy of Huntington’s Disease |
| Robert Foster | Pharmacokinetics and Pharmacodynamics of CRV431 for Treatment of NASH |
| Barik S. Mohammed | Transethosomes a Novel Transdermal Drug Delivery System for Antifungal Drugs |
| Eelko Hak | Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort study with the pharmacy database iaDB.nl: The PharmLines initiative |
| Rudolf Brenneisen | Pharmacokinetics of cannabinoids |
| Raha Rahbari | Transdermal delivery using Microstructures |
| Michael Holden | Healthy Living Pharmacy – its role in medicines optimisation and safety, prevention and protection within an integrated health system |
| Steven Finkbeiner | Cell death assays for neurodegenerative disease drug discovery |
| Bryan Bellaire | Gut Organoid as a New Platform to Study Alginate and Chitosan Mediated PLGA Nanoparticles for Drug Delivery |
| Nathalie Wagner | Clinical Pharmacology and Safety of Trifarotene, a First-in-Class RAR gamma-Selective Topical Retinoid |
| Sakurako Neo | Characterization of Suicidal Erythrocyte Death (Eryptosis) in Dogs |
| Joseph M Keenan | The Superfecta of Healthy Aging |
| Beate Bittner | Connected drug delivery devices to complement drug treatments: potential to facilitate disease management in home setting |
| Richard Weinshilboum | Pharmacogenomics: Precision Medicine and Drug Response |
| Stephen Ruberg | Inference and Decision Making for 21st-Century Drug Development and Approval |
| Norbert Lange | Cyclopeptidic photosensitizer prodrugs as proteolytically triggered drug delivery systems of pheophorbide A: part I – self-quenched prodrugs† |
| Fischer Sally | Point-of-care and utility in clinical trials: making quicker decisions to transform patient care and drug development |
| Moyassar I. AHMED, | Using Quality Risk Management in Pharmaceutical Industries: A Case Study |
| Chao Wang | Engineering Cell-derived nanoparticles for Immunotherapy Delivery |
| Chao Fang | Nanobowl-Supported Liposomes Improve Drug Loading and Delivery |
| Janet Scott | Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: plasma concentrations exceed target levels, with drug accumulation in the most severe patients |
| Jann N Sarkaria | Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma |
| Paul Y Takahashi | No Association Between Pharmacogenomics Variants and Hospital and Emergency Department Utilization: A Mayo Clinic Biobank Retrospective Study |
| Seira Toyosat | The influence of intervening on the pharmaceutical consultation targeting outpatients with advanced non-small cell lung cancer receiving erlotinib treatment |
| Colin Wright | Cryptolepine – a lead towards ‘green’ novel antimalarial and antitrypanosomal drugs? |
| Paula DeVos | Rosewater and Philosophers’ Oil: Thermo-chemical processing in medieval and early modern Spanish pharmacy |
| Dingpei Long | Genetically modified silk fibroin nanoparticles for drug delivery: preparation strategies and application prospects |
| Shaimaa ElShebiney | Newly developed controlled release subcutaneous formulation for tramadol hydrochloride |
| Simon Huff | Methodical process digitization – The process-driven approach (PDA) in its application to the pharmaceutical sector |
| Débora F. Carneiro | ACTIVISM FOR JUDICIAL EXTREMISM IN PUBLIC PHARMACEUTICAL ASSISTANCE POLICIES/DO ATIVISMO PARA O EXTREMISMO JUDICIAL NAS POLITICAS PUBLICAS DE ASSISTENCIA FARMACEUTICA” |
| William E. Fahl | A New Orally Active_ Aminothiol Radioprotector-Free of Nausea and Hypotension Side Effects at Its Highest Radioprotective Doses |
| Alaa Abuzaid | Female pharmacists’ career perceptions in Saudi Arabia: A survey at an academic center in Jeddah |
| Miguel Tobias Bahia | A bone remodeling model governed by cellular micromechanics and physiologically based pharmacokinetics |
| Huangqingbo Sun | Evaluation of categorical matrix completion algorithms: toward improved active learning for drug discovery |
| Stanimir Kabaivanov | Modelling the Innovative Potential of Companies in the Pharmaceutical Industry in Bulgaria |
| Elisabetta Groaz | Synthesis and antiviral evaluation of cyclopentyl nucleoside phosphonates |
| Swarna Beesetti | Designed Synthesis of Nanostructured Magnetic Hydroxyapatite Based Drug Nanocarrier for Anti-Cancer Drug Delivery toward the Treatment of Human Epidermoid Carcinom |
| Tara Lovestead. | Determination of cannabinoid vapor pressures to aid in vapor phase detection of intoxication |
| Miyauchi Masato | Successful retrieval using ultrathin transnasal esophagogastroduodenoscopy of a significant amount of residual tricyclic antidepressant following serious toxicity: a case report |
| Jennifer Danielson | Essential Elements for Core Required Advanced Pharmacy Practice Experiences |
| Limor Meoded Danon | Time matters for intersex bodies: Between socio-medical time and somatic time |
| Hyunmin Ahn | Artificial intelligence method to classify ophthalmic emergency severity based on symptoms: a validation study |
| Yoji Inaba | Which part of community social capital is related to life satisfaction and self-rated health? A multilevel analysis based on a nationwide mail survey in Japan |
| Jingrui Yang | MG53 and disordered metabolism in striated muscle |
| Jose Barreto | Social Media and Web Presence for Patients and Professionals: Evolving Trends and Implications for Practice |
| Leslie John Griffiths | A challenging injury interpretation: could this be a stab wound |
| Susan Garfield | Health Technology Assessment for Molecular Diagnostics: Practices_ Challenges_ and Recommendations from the Medical Devices and Diagnostics Special Interest Group |
| Stefania Nobili | Pharmacogenetics in diffuse large B-cell lymphoma patients treated with R-CHOP |
| Speaker | Presentation Title |
|---|---|
| Allan Mathews | Therapeutic Drug Monitoring of Anti-Epileptic Drugs in a Tertiary Hospital in Malaysia. |
| Stephen Shrewsbury | The Upper Nasal Space: An efficient route for systemic drug delivery |
| Juan Sanchez-Ramos | Nanoparticles Designed for Nose-to-brain Delivery of Gene Therapy of Huntington’s Disease |
| Robert Foster | Pharmacokinetics and Pharmacodynamics of CRV431 for Treatment of NASH |
| Barik S. Mohammed | Transethosomes a Novel Transdermal Drug Delivery System for Antifungal Drugs |
| Eelko Hak | Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort study with the pharmacy database iaDB.nl: The PharmLines initiative |
| Rudolf Brenneisen | Pharmacokinetics of cannabinoids |
| Raha Rahbari | Transdermal delivery using Microstructures |
| Michael Holden | Healthy Living Pharmacy – its role in medicines optimisation and safety, prevention and protection within an integrated health system |
| Steven Finkbeiner | Cell death assays for neurodegenerative disease drug discovery |
| Bryan Bellaire | Gut Organoid as a New Platform to Study Alginate and Chitosan Mediated PLGA Nanoparticles for Drug Delivery |
| Nathalie Wagner | Clinical Pharmacology and Safety of Trifarotene, a First-in-Class RAR gamma-Selective Topical Retinoid |
| Sakurako Neo | Characterization of Suicidal Erythrocyte Death (Eryptosis) in Dogs |
| Joseph M Keenan | The Superfecta of Healthy Aging |
| Beate Bittner | Connected drug delivery devices to complement drug treatments: potential to facilitate disease management in home setting |
| Richard Weinshilboum | Pharmacogenomics: Precision Medicine and Drug Response |
| Stephen Ruberg | Inference and Decision Making for 21st-Century Drug Development and Approval |
| Norbert Lange | Cyclopeptidic photosensitizer prodrugs as proteolytically triggered drug delivery systems of pheophorbide A: part I – self-quenched prodrugs† |
| Fischer Sally | Point-of-care and utility in clinical trials: making quicker decisions to transform patient care and drug development |
| Moyassar I. AHMED, | Using Quality Risk Management in Pharmaceutical Industries: A Case Study |
| Chao Wang | Engineering Cell-derived nanoparticles for Immunotherapy Delivery |
| Chao Fang | Nanobowl-Supported Liposomes Improve Drug Loading and Delivery |
| Janet Scott | Pharmacokinetics of TKM-130803 in Sierra Leonean patients with Ebola virus disease: plasma concentrations exceed target levels, with drug accumulation in the most severe patients |
| Jann N Sarkaria | Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma |
| Paul Y Takahashi | No Association Between Pharmacogenomics Variants and Hospital and Emergency Department Utilization: A Mayo Clinic Biobank Retrospective Study |
| Seira Toyosat | The influence of intervening on the pharmaceutical consultation targeting outpatients with advanced non-small cell lung cancer receiving erlotinib treatment |
| Colin Wright | Cryptolepine – a lead towards ‘green’ novel antimalarial and antitrypanosomal drugs? |
| Paula DeVos | Rosewater and Philosophers’ Oil: Thermo-chemical processing in medieval and early modern Spanish pharmacy |
| Dingpei Long | Genetically modified silk fibroin nanoparticles for drug delivery: preparation strategies and application prospects |
| Shaimaa ElShebiney | Newly developed controlled release subcutaneous formulation for tramadol hydrochloride |
| Simon Huff | Methodical process digitization – The process-driven approach (PDA) in its application to the pharmaceutical sector |
| Débora F. Carneiro | ACTIVISM FOR JUDICIAL EXTREMISM IN PUBLIC PHARMACEUTICAL ASSISTANCE POLICIES/DO ATIVISMO PARA O EXTREMISMO JUDICIAL NAS POLITICAS PUBLICAS DE ASSISTENCIA FARMACEUTICA” |
| William E. Fahl | A New Orally Active_ Aminothiol Radioprotector-Free of Nausea and Hypotension Side Effects at Its Highest Radioprotective Doses |
| Alaa Abuzaid | Female pharmacists’ career perceptions in Saudi Arabia: A survey at an academic center in Jeddah |
| Miguel Tobias Bahia | A bone remodeling model governed by cellular micromechanics and physiologically based pharmacokinetics |
| Huangqingbo Sun | Evaluation of categorical matrix completion algorithms: toward improved active learning for drug discovery |
| Stanimir Kabaivanov | Modelling the Innovative Potential of Companies in the Pharmaceutical Industry in Bulgaria |
| Elisabetta Groaz | Synthesis and antiviral evaluation of cyclopentyl nucleoside phosphonates |
| Swarna Beesetti | Designed Synthesis of Nanostructured Magnetic Hydroxyapatite Based Drug Nanocarrier for Anti-Cancer Drug Delivery toward the Treatment of Human Epidermoid Carcinom |
| Tara Lovestead. | Determination of cannabinoid vapor pressures to aid in vapor phase detection of intoxication |
| Miyauchi Masato | Successful retrieval using ultrathin transnasal esophagogastroduodenoscopy of a significant amount of residual tricyclic antidepressant following serious toxicity: a case report |
| Jennifer Danielson | Essential Elements for Core Required Advanced Pharmacy Practice Experiences |
| Limor Meoded Danon | Time matters for intersex bodies: Between socio-medical time and somatic time |
| Hyunmin Ahn | Artificial intelligence method to classify ophthalmic emergency severity based on symptoms: a validation study |
| Yoji Inaba | Which part of community social capital is related to life satisfaction and self-rated health? A multilevel analysis based on a nationwide mail survey in Japan |
| Jingrui Yang | MG53 and disordered metabolism in striated muscle |
| Jose Barreto | Social Media and Web Presence for Patients and Professionals: Evolving Trends and Implications for Practice |
| Leslie John Griffiths | A challenging injury interpretation: could this be a stab wound |
| Susan Garfield | Health Technology Assessment for Molecular Diagnostics: Practices_ Challenges_ and Recommendations from the Medical Devices and Diagnostics Special Interest Group |
| Stefania Nobili | Pharmacogenetics in diffuse large B-cell lymphoma patients treated with R-CHOP |
